Isleworth Healthcare Acquisition Corp. (ISLE)
| Market Cap | 213.62M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 22.00M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 17 |
| Last Price | $9.71 |
| Previous Close | $9.75 |
| Change ($) | -0.04 |
| Change (%) | -0.41% |
| Day's Open | 9.75 |
| Day's Range | 9.71 - 9.71 |
| Day's Volume | 1,000 |
| 52-Week Range | 9.60 - 9.85 |
ST. PETERSBURG, Fla., June 3, 2021 /PRNewswire/ -- Isleworth Healthcare Acquisition Corp. (NASDAQ: ISLE) (the "Company") announced today announced that on May 28, 2021 it received a notice ("Notice") fr...
ST. PETERSBURG, Fla., March 25, 2021 /PRNewswire/ -- Isleworth Healthcare Acquisition Corp. (NASDAQ: ISLEU) (the "Company") announced today that, on March 29, 2021, the Company's units will no longer tr...
Isleworth Healthcare Acquisition Corp. (NASDAQ: ISLEU) (the "Company") announced today the closing of its initial public offering of 20,700,000...
Isleworth Healthcare Acquisition Corp. (NASDAQ: ISLEU) (the "Company") announced today that it priced its initial public offering of 18,000,000...
Isleworth Healthcare Acquisition Corp. has filed to go public with an IPO on the NASDAQ.
About ISLE
Isleworth Healthcare Acquisition is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It is our intention to pursue prospective targets that are focused on healthcare innovation. We anticipate targeting companies domiciled in North America, Europe and Asia that are developing assets in the biopharmaceutical and, medical technology/medical device space, which aligns with our management team’s experien... [Read more...]
| Industry Blank Checks / SPAC | IPO Date Feb 25, 2021 |
| CEO Robert Whitehead | Country United States |
| Stock Exchange NASDAQ | Ticker Symbol ISLE |